← Leaderboards
Micheala A Aldred
Cleveland Clinic Lerner Com-Cwru
$9,408,014
Attributed
$11,413,820
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2010–24$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,413,820 · 5
By mechanism
R35$5,634,173 · 1
R01$3,115,390 · 2
R24$2,507,257 · 1
R03$157,000 · 1
Top collaborators
- Serpil C. Erzurum1 shared
- William E. Grizzle1 shared
- Vallerie Mclaughlin1 shared
- Marlene Rabinovitch1 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Yuxin Wang$1,529,500
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationLungAffectHeart FailureLifeBlood VesselsPublic Health RelevanceGeneticCellsEtiologyChromosome AbnormalityComplexStructure Of Parenchyma Of LungPulmonary Artery Endothelial CellInheritedEndothelial CellsMolecularPulmonary HypertensionLeadBloodDisorder PreventionSomatic MutationPathway InteractionsReactive Oxygen Species
Grant awards (24)
Genomics of Pulmonary Vascular Disease$765,962
R35 · FY2024 · HL · contact PI
Genomics of Pulmonary Vascular Disease$43,851
R35 · FY2024 · HL · contact PI
Genomics of Pulmonary Vascular Disease$776,771
R35 · FY2023 · HL · contact PI
Genomics of Pulmonary Vascular Disease$68,645
R35 · FY2023 · HL · contact PI
Genomics of Pulmonary Vascular Disease$776,912
R35 · FY2022 · HL · contact PI
Genomics of Pulmonary Vascular Disease$68,645
R35 · FY2022 · HL · contact PI
Genomics of Pulmonary Vascular Disease$24,416
R35 · FY2022 · HL · contact PI
Genomics of Pulmonary Vascular Disease$777,048
R35 · FY2021 · HL · contact PI
Genomics of Pulmonary Vascular Disease$777,180
R35 · FY2020 · HL · contact PI
Genomics of Pulmonary Vascular Disease$777,309
R35 · FY2019 · HL · contact PI
Genomics of Pulmonary Vascular Disease$777,434
R35 · FY2018 · HL · contact PI
Pulmonary Hypertension Breakthrough Initiative$2,507,257
R24 · FY2017 · HL · contact PI
Nonsense Readthrough: a Therapeutic Approach to Inherited Vascular Disorders$209,475
R01 · FY2017 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$196,936
R01 · FY2017 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$192,150
R01 · FY2017 · HL · contact PI
Nonsense Readthrough: a Therapeutic Approach to Inherited Vascular Disorders$186,775
R01 · FY2017 · HL · contact PI
Nonsense Readthrough: a Therapeutic Approach to Inherited Vascular Disorders$396,250
R01 · FY2016 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$390,306
R01 · FY2016 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$369,923
R01 · FY2013 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$388,575
R01 · FY2012 · HL · contact PI
Role of the X-chromosome in Pulmonary Arterial Hypertension$78,500
R03 · FY2012 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$392,500
R01 · FY2011 · HL · contact PI
Role of the X-chromosome in Pulmonary Arterial Hypertension$78,500
R03 · FY2011 · HL · contact PI
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension$392,500
R01 · FY2010 · HL · contact PI